Kin-ichi Imai

Title: Kin-ichi Imai: Innovator in Purine Derivatives

Introduction

Kin-ichi Imai is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of chemistry, particularly in the production of purine derivatives. With a total of 2 patents to his name, Imai's work has implications for both agricultural and veterinary medicine.

Latest Patents

Imai's latest patents focus on the production of purine derivatives and their intermediates. One of his key innovations is an improved process for producing purine derivatives, such as 9-(2-chloro-6-fluorobenzyl)-6-methylaminopurine. These compounds are recognized for their utility as anticoccidial agents. Additionally, he has developed new arylazopyrimidine compounds that serve as intermediates for the production of purine derivatives. These compounds exhibit anticoccidial activity and are beneficial for treating caecal and/or intestinal coccidiosis in poultry and domestic animals.

Career Highlights

Imai is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work at Takeda has allowed him to focus on innovative solutions that address critical health issues in animals. His research has contributed to advancements in the treatment of coccidiosis, a common disease affecting livestock.

Collaborations

Imai has collaborated with several esteemed colleagues, including Toshimi Matsuno and Mitsuhiko Mano. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.

Conclusion

Kin-ichi Imai's contributions to the field of purine derivatives highlight his innovative spirit and dedication to improving animal health. His patents reflect a commitment to advancing scientific knowledge and practical applications in veterinary medicine.